Sustainability Commitment

Our commitment reflects our focus on improving health and safety through a people-centric culture, ethical leadership, and climate stewardship.

Purpose-Driven and Future-Focused

Our mission to improve patient health and safety guides everything we do—and shapes our commitment to sustainability. This deep sense of responsibility is reflected in how we operate as a business, with a focus on People-Centric Culture, Ethical Leadership, and Climate Stewardship.

Our SBTi-validated emissions reduction targets and EcoVadis Commitment badge reflect continued progress, and as part of our journey, have detailed action plans to continuously improve our rating.

esg-badges

Sustainability Starts with Our Core Principles

 

People-Centric Culture

We foster a culture of respect, inclusion, and opportunity to enable employee well-being, professional growth, and a culture of belonging.

  • Dedicated DEI program and leadership
  • Risk inventory assessments
  • Volunteer and flexible time off
  • Wellness benefits, annual programming, and challenges
  • Employee Resource Groups and clubs
  • Feedback and upward mobility
  • Charity match programs
  • Talent acquisition and retention 
  • Mentorship programs
  • Training and continuous education opportunities
  • And more!
smiling-woman-high-fiving-coworker-as-983431523-650x425
Confident worker woman looking at camera

Ethical Leadership

We uphold integrity, transparency, and accountability in all aspects of our business, ensuring responsible decision-making, data privacy, and compliance with global standards.

  • Advanced Data Security and Privacy Programs
  • Compliance with labor laws within each operating region
  • Quarterly Board Reporting on Sustainability Program
  • Transparent and accessible leadership through Town Halls

Climate Stewardship

We are focused on minimizing our environmental footprint through science-based climate action, responsible resource management, and continuous improvement in sustainability practices.

  • Remote workforce commitment
  • Employee Education & Green Team
  • EcoVadis Commitment Badge
  • Approved near- and long-term science-based emissions reduction targets with the Science Based Targets initiative (SBTi)
  • Annual energy and carbon reporting

Our near-term and long-term emissions reduction targets have been independently validated by SBTi Services in accordance with the SBTi Near-Term and Net-Zero Criteria.

Group of professional women talking in a lobby
Gradient Image

Driving Progress Through Collaboration 

Our Sustainability Program is guided by a dedicated Steering Committee made up of executive and senior leaders from across our global operations. This cross-functional group is responsible for driving progress across all pillars of our sustainability strategy. The committee ensures accountability, approves new initiatives, and proactively plans for evolving regional requirements and standards to maintain meaningful, forward-looking impact.

News & Insights

Offshoring Medical Information Services: A Breakthrough Trend to Achieve 24/7 Global Market Reach

April 20, 2026

Offshoring Medical Information Services: A Breakthrough Trend to Achieve 24/7 Gl...

Explore the benefits of offshoring medical information services, enhancing global support and operational flexibility for healthcare and pharmaceutical companies.

Preparing for EMA Policy 0070: How to Stay Ahead of the Anonymization Curve

April 16, 2026

Preparing for EMA Policy 0070: How to Stay Ahead of the Anonymization Curve

Prepare for EMA Policy 0070 by understanding anonymization requirements, project management strategies, and best practices to ensure a smooth submission process.

Navigating Medical Inquiries Across Europe: Why Multilingual Support Matters for MAHs

April 13, 2026

Navigating Medical Inquiries Across Europe: Why Multilingual Support Matters for...

Discover why multilingual support and regional expertise are crucial for Marketing Authorization Holders (MAHs) to deliver consistent, compliant Medical Information across Europe's diverse landscape.

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero Targets

January 27, 2026

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero T...

ProPharma’s greenhouse gas reduction targets are validated by SBTi, aligning with the Net-Zero Standard and a commitment to reach net-zero by 2050.

ProPharma Expands Operations with New Office in Hyderabad

December 11, 2025

ProPharma Expands Operations with New Office in Hyderabad

ProPharma expands with a new office in Hyderabad, enhancing innovation and growth in regulatory, clinical, and compliance services for the life sciences industry.

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Case Study Reducing Patient Burden While Maintaining High-Frequency  Monitoring in a Hemophilia Gene  Therapy Trial

April 20, 2026

Reducing Patient Burden While Maintaining High-Frequency Monitoring in a Hemoph...

Balancing rigorous clinical oversight with patient accessibility is critical in complex gene therapy trials. Intensive early-phase monitoring and complex protocols can place significant burden on...

Case Study Ensure Launch Readiness—Even on the Tightest Timelines

March 30, 2026

Ensure Launch Readiness, Even on the Tightest Timelines

Expediting Promotional Review to Deliver 60+ Materials in Just 4 Weeks When timelines are compressed and stakes are high, promotional review processes can quickly become a bottleneck. This case study...

Case Study How a Novel Real World Evidence Strategy Helped Bring a Class III Device to Market - ProPharma

March 23, 2026

Real World Evidence for Class III Devices: A Smarter Path to PMA

Struggling to generate clinical evidence for Class III devices without costly, multi-year trials? Discover how ProPharma helped an orthopedic device company leverage existing registry data to support...

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

April 23, 2026

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

As cell and gene therapies transition from clinical development to commercialization, organizations face evolving regulatory expectations, expanded CMC requirements, and increased MAH...

EMA Policy 0070: Advanced Strategies for Compliance, Anonymization, and CCI Justification

April 9, 2026

EMA Policy 0070: Advanced Strategies for Compliance, Anonymization, and CCI Justification

As European Medicines Agency Policy 0070 enters its expanded Step 2 phase, sponsors face increased document volumes, heightened transparency obligations, and greater scrutiny of anonymization and CCI...

Mastering the PSMF: The Pillar of Inspection Readiness for MAHs, LPPVs & QPPVs

March 12, 2026

Mastering the PSMF: The Pillar of Inspection Readiness for MAHs, LPPVs & QPPVs

Uncover the intricacies of Pharmacovigilance System Master File (PSMF) management and explore proven strategies to ensure inspection readiness, effective MAH oversight, and regulatory compliance...

News & Insights

Offshoring Medical Information Services: A Breakthrough Trend to Achieve 24/7 Global Market Reach

April 20, 2026

Offshoring Medical Information Services: A Breakthrough Trend to Achieve 24/7 Gl...

Explore the benefits of offshoring medical information services, enhancing global support and operational flexibility for healthcare and pharmaceutical companies.

Preparing for EMA Policy 0070: How to Stay Ahead of the Anonymization Curve

April 16, 2026

Preparing for EMA Policy 0070: How to Stay Ahead of the Anonymization Curve

Prepare for EMA Policy 0070 by understanding anonymization requirements, project management strategies, and best practices to ensure a smooth submission process.

Navigating Medical Inquiries Across Europe: Why Multilingual Support Matters for MAHs

April 13, 2026

Navigating Medical Inquiries Across Europe: Why Multilingual Support Matters for...

Discover why multilingual support and regional expertise are crucial for Marketing Authorization Holders (MAHs) to deliver consistent, compliant Medical Information across Europe's diverse landscape.

Previous Post Arrow Next Post Arrow
ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero Targets

January 27, 2026

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero T...

ProPharma’s greenhouse gas reduction targets are validated by SBTi, aligning with the Net-Zero Standard and a commitment to reach net-zero by 2050.

ProPharma Expands Operations with New Office in Hyderabad

December 11, 2025

ProPharma Expands Operations with New Office in Hyderabad

ProPharma expands with a new office in Hyderabad, enhancing innovation and growth in regulatory, clinical, and compliance services for the life sciences industry.

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

Previous Post Arrow Next Post Arrow
ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Previous Award Arrow Next Award Arrow
Case Study Reducing Patient Burden While Maintaining High-Frequency  Monitoring in a Hemophilia Gene  Therapy Trial

April 20, 2026

Reducing Patient Burden While Maintaining High-Frequency Monitoring in a Hemoph...

Balancing rigorous clinical oversight with patient accessibility is critical in complex gene therapy trials. Intensive early-phase monitoring and complex protocols can place significant burden on...

Case Study Ensure Launch Readiness—Even on the Tightest Timelines

March 30, 2026

Ensure Launch Readiness, Even on the Tightest Timelines

Expediting Promotional Review to Deliver 60+ Materials in Just 4 Weeks When timelines are compressed and stakes are high, promotional review processes can quickly become a bottleneck. This case study...

Case Study How a Novel Real World Evidence Strategy Helped Bring a Class III Device to Market - ProPharma

March 23, 2026

Real World Evidence for Class III Devices: A Smarter Path to PMA

Struggling to generate clinical evidence for Class III devices without costly, multi-year trials? Discover how ProPharma helped an orthopedic device company leverage existing registry data to support...

Previous Resource Arrow Next Resource Arrow
Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

April 23, 2026

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

As cell and gene therapies transition from clinical development to commercialization, organizations face evolving regulatory expectations, expanded CMC requirements, and increased MAH...

EMA Policy 0070: Advanced Strategies for Compliance, Anonymization, and CCI Justification

April 9, 2026

EMA Policy 0070: Advanced Strategies for Compliance, Anonymization, and CCI Justification

As European Medicines Agency Policy 0070 enters its expanded Step 2 phase, sponsors face increased document volumes, heightened transparency obligations, and greater scrutiny of anonymization and CCI...

Mastering the PSMF: The Pillar of Inspection Readiness for MAHs, LPPVs & QPPVs

March 12, 2026

Mastering the PSMF: The Pillar of Inspection Readiness for MAHs, LPPVs & QPPVs

Uncover the intricacies of Pharmacovigilance System Master File (PSMF) management and explore proven strategies to ensure inspection readiness, effective MAH oversight, and regulatory compliance...

Previous Webinar Arrow Next Webinar Arrow